The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity

Current Opinion in Genetics and Development

Volumn 12, Issue 1, 2002, Pages 86-91

  Baer, Richard ^a   Ludwig, Thomas ^b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

CANCER INHIBITION; CARCINOGENESIS; ENZYME ACTIVITY; HUMAN; MOLECULAR MECHANICS; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0036467574     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(01)00269-6     Document Type: Review

References (70)

1. Hereditary breast cancer
2. The genetics of breast cancer susceptibility
3. Breast cancer genetics: What we know and what we need
4. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
5. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds
6. Identification of the breast cancer susceptibility gene BRCA2
7. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome
8. Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice
9. Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation
10. Double-strand-break-induced homologous recombination in mammalian cells
11. DNA polymerase stalling, sister chromatid recombination and the BRCA genes
12. Roles of BRCA1 and its interacting proteins
13. In search of the tumour-suppressor functions of BRCA1 and BRCA2
14. Chromosome stability, DNA recombination and the BRCA2 tumour suppressor
15. BRCA1: Exploring the links to transcription
16. BRCA1 at a branch point
17. BRCA1 protein products: Functional motifs
18. RING for destruction?
19. RING finger proteins: Mediators of ubiquitin ligase activity
20. Proteolysis and the cell cycle: With this RING I do thee destroy
21. Does this have a familiar RING?
22. The breast cancer information core: Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene
23. A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: Implications for presymptomatic testing and screening
24. Identification of a RING protein that can interact in vivo with the BRCA1 gene product
25. Cell-cycle dependent colocalization of BARD1 and BRCA1 in discrete nuclear domains
26. Nuclear localization and cell cycle-specific expression of CtIP, a protein that associates with the BRCA1 tumor suppressor
27. Structure of a BRCA1/BARD1 heterodimeric RING-RING complex
28. In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells
29. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50
30. The BARD1-CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression
31. Nine novel conserved motifs in BRCA1 identified by the chicken orthologue
32. Conservation of function and primary structure in the BRCA1-associated RING domain (BARD1) protein
33. Genomic structure of the BRCA1-associated RING domain (BARD1) gene reveals a novel germline alteration in a patient with primary cancers of the breast, ovary and endometrium
34. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
35. Association of BRCA1 with Rad51 in mitotic and meiotic cells
36. Stable interation between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and mieotic cells
37. S phase specific formation of the human Rad51 protein nuclear foci in lymphocytes
38. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro
39. BRCA1, BRCA2, and DNA damage response: Collision or collusion?
40. Brca1 controls homology-directed DNA repair
41. Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation
42. BRCA1 required for transcription-coupled repair of oxidative DNA damage
43. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells
44. Involvement of Brca1 in S-phase and G(2)-phase checkpoints after ionizing irradiation
45. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells
46. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures
47. Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage
48. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks
49. Role for ATM in DNA damage-induced phosphorylation of BRCA1
50. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies
51. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response
52. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress
53. Genetic instabilities in human cancers
54. Mechanisms underlying ubiquitination
55. Themes and variations on ubiquitylation
56. Defining polyubiquitin chain topology
57. The lore of the RINGs: Substrate recognition and catalysis by ubiquitin ligases
58. RING fingers mediate ubiquitin-conjugating enzyme (E2)-dependent ubiquitination
59. Cancer predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity
60. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
61. BAP1: A novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression
62. Regulation of ubiquitin-dependent processes by deubiquitinating enzymes
63. Protein regulation by monoubiquitin
64. Redistribution of BRCA1 among four different protein complexes following replication blockage
65. The C-terminal domain of RNA polymerase II couples mRNA processing to transcription
66. BRCA1 is a component of the RNA polymerase II holoenzyme
67. Ubiquitination of RNA polymerase II large subunit signaled by phosphorylation of carboxyl-terminal domain
68. Ultraviolet radiation-induced ubiquitination and proteasomal degradation of the large subunit of RNA polymerase II. Implications for transcription-coupled DNA repair
69. Positional cloning of a novel Fanconi anemia gene, FANCD2
70. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway